| Financial Year |
March 31 2023 |
| Monetary Funds |
4,251,203,757.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
26,540,108.94 |
| Accounts Receivable |
1,001,980,274.91 |
| Advances to Suppliers |
392,583,146.00 |
| Other Receivables |
324,787,756.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,142,599,656.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,231,920.00 |
| Total Current Assets |
8,448,791,265.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,296,326,724.09 |
| Long-term Equity Investment |
10,470,681,635.94 |
| Investment Properties |
2,258,872.00 |
| Fixed Assetes |
45,892,929,003.46 |
| Under-construction Projects |
1,290,136,102.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,847,409.82 |
| R&D expenses |
-- |
| Goodwill |
73,324,705.01 |
| Long-Term Deferred and Prepaid Expenses |
3,674,556.60 |
| Deferred Income Tax Assets |
37,920,277.39 |
| Other Non-Current Assets |
196,773,608.25 |
| Sub-Total of Non-Current Assets |
60,372,874,554.25 |
| Total Assets |
68,821,665,819.68 |
| Short-Term Loans |
4,042,529,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,538,942.90 |
| Accounts Payable |
2,737,251,515.49 |
| Accounts Received In Advance |
74,505,238.73 |
| Employee Compensation Payable |
468,597,328.56 |
| Taxes Payable |
311,430,069.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
488,975,571.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,075,937,657.89 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
10,405,325,409.71 |
| Long-term Loans |
19,797,987,306.90 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
968,598,643.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,058,595.90 |
| Deferred Income Tax Liabilities |
1,272,424,851.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,565,640,788.85 |
| Total Liabilities |
33,970,966,198.56 |
| Paid-In Capital(Or Share Stock) |
4,770,776,395.00 |
| Capital Surplus |
11,980,636,063.70 |
| Surplus Reserve |
2,877,436,346.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,173,314,277.41 |
| Minority Stockholder's Interest |
2,155,178,214.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
32,695,521,406.91 |
| Owner's Equity（Stockholder's Equity） |
34,850,699,621.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
68,821,665,819.68 |
